02/14/2024
2:38 PM | Ayrton Capital LLC (Filed by)
PharmaCyte Biotech (Subject)
| Form SC 13G | |
02/06/2024
8:56 AM | INTRACOASTAL CAPITAL, LLC (Filed by)
PharmaCyte Biotech (Subject)
| Form SC 13G/A | |
12/15/2023
4:25 PM | PharmaCyte Biotech (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/24/2023
3:00 PM | PharmaCyte Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2023
4:01 PM | PharmaCyte Biotech (Issuer)
Silverman Joshua (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
4:01 PM | PharmaCyte Biotech (Issuer)
Trujillo Carlos (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
4:02 PM | PharmaCyte Biotech (Issuer)
WALKER WAYNE REMELL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
11/22/2023
4:02 PM | PharmaCyte Biotech (Issuer)
WEINSTEIN ROBERT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2023
7:45 PM | PharmaCyte Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
4:25 PM | PharmaCyte Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2023
11:15 PM | PharmaCyte Biotech (Filer)
| Form EFFECT | |
09/21/2023
4:04 PM | PharmaCyte Biotech (Filer)
| Form S-3/A | |
09/18/2023
5:04 AM | PharmaCyte Biotech (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/15/2023
4:00 PM | PharmaCyte Biotech (Filer)
| Form NT 10-Q | |
09/11/2023
8:56 PM | PharmaCyte Biotech (Filer)
| Form S-3/A | |
09/07/2023
3:05 PM | PharmaCyte Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/04/2023
3:40 PM | PharmaCyte Biotech (Filer)
| Form S-3/A | |
07/31/2023
3:42 PM | PharmaCyte Biotech (Filer)
| Form DEF 14A | |
07/19/2023
9:28 AM | PharmaCyte Biotech (Filer)
| Form PRE 14A | |
07/18/2023
6:05 PM | PharmaCyte Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
4:22 PM | Iroquois Capital Management, LLC (Filed by)
PharmaCyte Biotech (Subject)
| Form SC 13D/A | |
05/25/2023
4:13 PM | PharmaCyte Biotech (Filer)
| Form PRE 14A | |
05/19/2023
4:19 PM | Ayrton Capital LLC (Filed by)
PharmaCyte Biotech (Subject)
| Form SC 13G | |
05/12/2023
3:22 PM | Iroquois Capital Management, LLC (Filed by)
PharmaCyte Biotech (Subject)
| Form SC 13D/A | |
05/11/2023
7:35 AM | PharmaCyte Biotech (Subject)
| Form SC TO-I | |
05/11/2023
7:30 AM | PharmaCyte Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
